These observations were supported by our mutagenesis studies, where mutations R299 ECL2 A in GLP-1R, R289 ECL2 A in GIPR and I194 2.67b K in GCGR caused variable decreases in retatrutide potency (by 3.7-fold, 4.6-fold and 36.0-fold, respectively), while S297 ECL2 A in GCGR slightly increased retatrutide potency
purity 99.69% Avg
They are generating mice in which the protein SPHKAP can be specifically deleted from -cells, allowing them to examine how disrupting this signalling hub affects pancreatic function and GLP-1R signalling
The provider will review your health information and decide whether to issue a prescription
Thats why its important to work with your care team to find the right dosage for you, rather than skipping doses or adjusting dosage on your own, he says
For details on known side effects, see our retatrutide side effects guide